Healio

FDA approves once-weekly basal insulin for adults with type 2 diabetes

The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
MPR

RSV Vaccine Arexvy Approved for At-Risk Adults Aged 18 to 49 Years

Adults aged 18 to 49 years at increased risk for RSV-associated lower respiratory tract disease are now eligible for the Arexvy vaccine.
Al Bawaba

Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the first ...
Monthly Prescribing Reference

Sotyktu Receives FDA Approval for Adults With Active Psoriatic Arthritis

In the POETYK PsA-1 and PsA-2 phase 3 trials, deucravacitinib demonstrated superior efficacy over placebo in achieving ACR20 response at week 16. The Food and Drug Administration (FDA) has approved ...